Product Ref: BADIN01 Category: D
Royal Mail 2nd Class / Parcel Force 48
UK to UK :Normally arrives in 2-4 business days.
UK to Ireland :Normally arrives in 4-6 business days
UK to EU Countries : Normally arrives in 6-10 working days depending on where the parcel is going
Please note standered delivery is none trackable , none insured , no responsabily for lose or Damage
----------------------------------------------------------------------------------------------------------------
Royal Mail First Class / Parcel Force 24
UK to UK :Normally arrives in 1-2 business days.
UK to Ireland 3-4 business days
UK to EU Countries : Normally arrives in 6-10 working days depending on where the parcel is going
Please note :Trackable , Royal Mail insured up to £50.
--------------------------------------------------------------------------------------------------------
Parcel Force Express AM Guaranteed before Midday.
UK to UK only . UP to 5KG Max Weight
Arrives next day before 12 noon, requires a signature.
Parcel Forcel Terms & Conditions apply
Important: Parcel Force advise that there are some postcodes where an extended delivery time exists, and may affect the date of delivery or the service is not available.
| Category | POM-V |
| Temperature | Ambient |
| MA/VM/EU No: | 46037/4003 |
| Species |
|
| VMD Link | Product Information Database (defra.gov.uk) |
| NOAH Link | https://www.noahcompendium.co.uk/?id=-446497 |
| Dosage | For intravenous or intramuscular use. Cattle Administer the product via the intravenous or intramuscular route, preferably in the neck region, at a dose of 3 mg of ketoprofen/kg bw/day, equivalent to 1 ml/50 kg bw/day of the product. The duration of treatment is 1-3 days, and should be established according to the severity and duration of symptoms. Pigs Administer the product via the intramuscular route at a dose of 3 mg of ketoprofen/kg bw equivalent to 1 ml/50 kg bw/day of the product, on a single occasion. Depending on the response observed and based on the benefit-risk analysis by the responsible veterinarian treatment may be repeated at intervals of 24 hours for a maximum of three treatments. Each injection should be given at a different site. Horses Administer via the intravenous route at a dose of 2.2 mg of ketoprofen/kg bw/day, equivalent to 0.75 ml/50 kg bw/day of the product. The duration of treatment is 1-5 days, and should be established according to the severity and duration of symptoms. In the case of colic one injection is normally sufficient. A second administration of ketoprofen requires a clinical re-examination. Use during pregnancy and lactation Pregnancy: Studies in laboratory animals (rats, mice, rabbits) and cattle have not produced any evidence of adverse effects. Can be used in pregnant cows. The safety of the veterinary medicinal product has not been established during pregnancy in sows and mares. Use only accordingly to the benefit-risk assessment by the responsible veterinarian Lactation Can be used in lactating cows and sows. The use is not recommended in lactating mares. |
| Withdrawals | ent, necrotic subclinical muscular lesions that gradually resolve in the days after completion of treatment. Administration in the neck region minimises the extension and severity of these lesions. In horses, transient local reactions, which disappeared after 5 days, were observed after one administration of the product at the recommended volume by extravascular route. Due to the mechanism of action of ketoprofen, after repeated administrations, erosive and ulcerative lesions of the gastrointestinal tract may occur. In common with all NSAIDs due to their action of inhibition of prostaglandins synthesis, there can be the possibility in certain individuals of gastric or renal intolerance. If side effects occur treatment must be stopped and the advice of a veterinarian should be sought. Concurrent administration of diuretics or potentially nephrotoxic drugs should be avoided since there is an increased risk of renal disturbances, including renal failure. This is secondary to the diminished blood flow caused by the inhibition of prostaglandins synthesis. Do not administer other non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, anticoagulants or diuretics concurrently or within 24 hours of administration of the product since the risk of gastrointestinal ulceration and other adverse reactions may be exacerbated. The treatment free period should however take into account the pharmacological properties of the products used previously. Ketoprofen is highly bound to plasma proteins and may compete with other highly bound drugs which can lead to toxic effects. Overdose with non-steroidal anti-inflammatory drugs can lead to gastro-intestinal ulceration, loss of proteins, hepatic and renal impairment. In tolerance studies performed in pigs, up to 25% of the animals treated at three times the maximum recommended dose (9 mg/kg bw) for three days or at the recommended dose (3 mg/kg bw) for triple the maximum recommended time (9 days) showed erosive and/or ulcerative lesions in both the aglandular (pars oesophagica) and glandular parts of the stomach. Early signs of toxicity include loss of appetite and pasty faeces or diarrhoea. The intramuscular administration of the product to cattle, at up to 3 times the recommended dose or for 3 times the recommended duration of the treatment (9 days) did not result in clinical signs of intolerance. However, inflammation as well as necrotic subclinical lesions were detected at the injection site of the treated animals as well as an increase in CPK levels. The histopathological examination showed erosive or ulcerative abomasal lesions related to both dosage regimes. Horses have been found to tolerate intravenous dosages of ketoprofen up to 5 times the recommended dose for three times the recommended duration (15 days) with no evidence of toxic effects. If clinical signs of overdose are observed, there is no specific antidote, therefore symptomatic treatment should be initiated. Withdrawal period(s) Cattle: •Meat and offal: 2 days •Milk: zero hours Horses: •Meat and offal: 1 day •Milk: Not authorised for use in mares producing milk for human consumption Pigs: •Meat and offal: 3 days User Safety Avoid contact with the skin, eyes and mucous membranes. In case of accidental skin, eye or mucous membrane contact, wash the affected area thoroughly with clean running water immediately. Seek medical advice if irritation persists. Avoid accidental self-injection. In case of accidental self-injection, seek medical advice immediately and show the package leaflet or the label to the physician. Wash hands after use. Hypersensitivity reactions (skin rash, urticaria) could occur. People with known hypersensitivity to the active substance or to any of the excipients should avoid contact with the veterinary medicinal product. People with known hypersensitivity to the active substance or to any of the excipients should avoid contact with the veterinary medicinal product. Environmental Safety Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements. |
